Glaukos Corp

Glaukos Corporation is a leading medical technology company that specializes in developing and commercializing innovative products and procedures for the treatment of glaucoma, a major cause of blindness worldwide. The company's flagship product, the iStent, is the first and only FDA-approved device for treating mild to moderate open-angle glaucoma. Glaukos also offers a range of other products and technologies, including the iStent inject, iStent infinite, and iDose, all designed to provide safe and effective solutions for glaucoma patients. With a strong commitment to improving patient outcomes and quality of life, Glaukos is dedicated to advancing ophthalmology through ongoing research and development, strategic partnerships, and a focus on innovation and excellence.